DuPont (DD) To Buy BASF's Ultrafiltration Membrane Business

 | Sep 24, 2019 08:57AM ET

DuPont de Nemours, Inc.’s (NYSE:DD) Safety & Construction unit has agreed to purchase the ultrafiltration membrane business from German chemical giant, BASF SE (DE:BASFN). The financial terms of the transaction were not divulged.

The acquisition includes the shares of inge GmbH, the international workforce of the business, its headquarters and production site in Greifenberg, Germany and specific intellectual property currently owned by BASF.

The transaction, which is subject to customary closing conditions and regulatory clearances, is expected to complete by the end of this year. The buyout will add to DuPont's portfolio of water purification and separation technologies that include ultrafiltration, reverse osmosis and ion exchange resins. It will expand the company’s water purification capabilities.

BASF’s ultrafiltration technology complements DuPont’s high-flow PVDF technology. In addition to expanding DuPont’s portfolio, the acquisition will enhance the company’s ability to design solutions for drinking water, industrial and waste water treatment applications on a worldwide basis. This will help DuPont to address rising customer demand.

DuPont, which was formerly known as DowDuPont Inc., started trading as a stand-alone company on Jun 3, 2019 following the separation of its Agriculture division through the spin-off of Corteva, Inc.

DuPont’s shares are down around 6.9% since it started trading on the NYSE, compared with the roughly 2.3% rise recorded by the industry .


The company, last month, raised its adjusted earnings per share guidance to the range of $3.75-$3.85 for 2019. It, however, sees organic sales for the year to be modestly down from last year. The company expects weak demand in its short-cycle businesses to continue in the second half.

The company benefited from its cost and pricing actions in the second quarter and noted that it is driving additional cost actions in the second half.

DuPont de Nemours, Inc. Price and Consensus

Zacks Investment Research

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes